4-Hydroxyphenylpyruvic acid

Identification

Generic Name
4-Hydroxyphenylpyruvic acid
DrugBank Accession Number
DB07718
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 180.1574
Monoisotopic: 180.042258744
Chemical Formula
C9H8O4
Synonyms
  • (4-hydroxyphenyl)pyruvic acid
  • (p-hydroxyphenyl)pyruvic acid
  • p-Hydroxyphenylpyruvic acid
External IDs
  • NSC-100738
  • NSC-666757

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UProthrombinNot AvailableHumans
UMacrophage migration inhibitory factorNot AvailableHumans
UPrephenate dehydrogenaseNot AvailableAquifex aeolicus (strain VF5)
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
PathwayCategory
PhenylketonuriaDisease
Tyrosine MetabolismMetabolic
Tyrosinemia Type IDisease
Tyrosinemia Type 3 (TYRO3)Disease
Disulfiram Action PathwayDrug action
Phenylalanine and Tyrosine MetabolismMetabolic
AlkaptonuriaDisease
HawkinsinuriaDisease
Tyrosinemia Type 2 (or Richner-Hanhart Syndrome)Disease
Tyrosinemia, Transient, of the NewbornDisease
Dopamine beta-Hydroxylase DeficiencyDisease
Monoamine Oxidase-A Deficiency (MAO-A)Disease
Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
Not Available

Interactions

Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as phenylpyruvic acid derivatives. These are compounds containing a phenylpyruvic acid moiety, which consists of a phenyl group substituted at the second position by an pyruvic acid.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Phenylpyruvic acid derivatives
Direct Parent
Phenylpyruvic acid derivatives
Alternative Parents
Phenylpropanoic acids / 1-hydroxy-2-unsubstituted benzenoids / Alpha-keto acids and derivatives / Alpha-hydroxy ketones / Monocarboxylic acids and derivatives / Carboxylic acids / Organic oxides / Hydrocarbon derivatives
Substituents
1-hydroxy-2-unsubstituted benzenoid / 3-phenylpropanoic-acid / Alpha-hydroxy ketone / Alpha-keto acid / Aromatic homomonocyclic compound / Carbonyl group / Carboxylic acid / Carboxylic acid derivative / Hydrocarbon derivative / Keto acid
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
phenols, oxo carboxylic acid (CHEBI:15999)
Affected organisms
Not Available

Chemical Identifiers

UNII
0YP1694WNQ
CAS number
156-39-8
InChI Key
KKADPXVIOXHVKN-UHFFFAOYSA-N
InChI
InChI=1S/C9H8O4/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-4,10H,5H2,(H,12,13)
IUPAC Name
3-(4-hydroxyphenyl)-2-oxopropanoic acid
SMILES
OC(=O)C(=O)CC1=CC=C(O)C=C1

References

General References
Not Available
Human Metabolome Database
HMDB0000707
KEGG Compound
C01179
PubChem Compound
979
PubChem Substance
99444189
ChemSpider
954
ChEBI
15999
ChEMBL
CHEMBL607712
ZINC
ZINC000000895711
PDBe Ligand
ENO
Wikipedia
4-Hydroxyphenylpyruvic_acid
PDB Entries
1ca7 / 3gac / 3ggo / 3tx6 / 3uk0 / 3ukj / 4eyq / 4jb0 / 4kig / 5zbf
show 1 more

Clinical Trials

Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility1.49 mg/mLALOGPS
logP1.12ALOGPS
logP1.6Chemaxon
logS-2.1ALOGPS
pKa (Strongest Acidic)2.91Chemaxon
pKa (Strongest Basic)-6Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count4Chemaxon
Hydrogen Donor Count2Chemaxon
Polar Surface Area74.6 Å2Chemaxon
Rotatable Bond Count3Chemaxon
Refractivity44.69 m3·mol-1Chemaxon
Polarizability16.75 Å3Chemaxon
Number of Rings1Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.8829
Blood Brain Barrier+0.6663
Caco-2 permeable-0.6945
P-glycoprotein substrateNon-substrate0.7002
P-glycoprotein inhibitor INon-inhibitor0.961
P-glycoprotein inhibitor IINon-inhibitor0.9607
Renal organic cation transporterNon-inhibitor0.9201
CYP450 2C9 substrateNon-substrate0.8473
CYP450 2D6 substrateNon-substrate0.9196
CYP450 3A4 substrateNon-substrate0.7244
CYP450 1A2 substrateNon-inhibitor0.9836
CYP450 2C9 inhibitorNon-inhibitor0.9768
CYP450 2D6 inhibitorNon-inhibitor0.9701
CYP450 2C19 inhibitorNon-inhibitor0.9761
CYP450 3A4 inhibitorNon-inhibitor0.965
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9844
Ames testNon AMES toxic0.896
CarcinogenicityNon-carcinogens0.9065
BiodegradationReady biodegradable0.8661
Rat acute toxicity1.7101 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9655
hERG inhibition (predictor II)Non-inhibitor0.9699
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies)GC-MSsplash10-002f-1920000000-75b07d9c09371340939f
GC-MS Spectrum - GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (3 TMS)GC-MSsplash10-00xr-9340000000-087aad2497b3493d27c0
GC-MS Spectrum - GC-MS (1 MEOX; 2 TMS)GC-MSsplash10-002o-5910000000-fd1e55c84c79bfeca559
GC-MS Spectrum - GC-MS (1 MEOX; 2 TMS)GC-MSsplash10-002f-1941000000-2b4c87544657895fcaf6
GC-MS Spectrum - GC-MS (1 MEOX; 3 TMS)GC-MSsplash10-014i-3492100000-483bdcea11d60fe4d306
GC-MS Spectrum - GC-MS (1 MEOX; 3 TMS)GC-MSsplash10-014i-6791000000-ddc0a3b695cd1d0769f2
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-0a4i-6900000000-91bfe3ee54a36877251b
GC-MS Spectrum - EI-BGC-MSsplash10-002f-1951000000-ecd071a64b26ca77684c
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-002f-1920000000-75b07d9c09371340939f
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-00xr-9340000000-087aad2497b3493d27c0
GC-MS Spectrum - GC-MSGC-MSsplash10-002o-5910000000-fd1e55c84c79bfeca559
GC-MS Spectrum - GC-MSGC-MSsplash10-002f-1941000000-2b4c87544657895fcaf6
GC-MS Spectrum - GC-MSGC-MSsplash10-014i-3492100000-483bdcea11d60fe4d306
GC-MS Spectrum - GC-MSGC-MSsplash10-014i-6791000000-ddc0a3b695cd1d0769f2
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-0006-2920000000-469469dfaad745fa78e8
GC-MS Spectrum - GC-EI-TOFGC-MSsplash10-002o-2910000000-4f336335a2366e7dd6db
Mass Spectrum (Electron Ionization)MSsplash10-0a59-5900000000-6c003e26816579df31ca
MS/MS Spectrum - Quattro_QQQ 10V, NegativeLC-MS/MSsplash10-0a4i-0900000000-12033042c41b550bed42
MS/MS Spectrum - Quattro_QQQ 25V, NegativeLC-MS/MSsplash10-0a4i-0900000000-6e8a3701c6d254cc824d
MS/MS Spectrum - Quattro_QQQ 40V, NegativeLC-MS/MSsplash10-0560-1900000000-8082c68e259d24234d05
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, NegativeLC-MS/MSsplash10-004i-0900000000-2416d7f64101b9473cbb
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, NegativeLC-MS/MSsplash10-0a4i-2900000000-b4c21b3d9751b9e56d67
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, NegativeLC-MS/MSsplash10-0005-9400000000-708e258e692a0abfbc92
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, NegativeLC-MS/MSsplash10-0002-9100000000-7d75e23ae6944c1e9c6d
LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 50V, NegativeLC-MS/MSsplash10-001m-9000000000-fb80dcbab23323a042af
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-004i-0900000000-2416d7f64101b9473cbb
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0a4i-2900000000-ad1f1fabdf6b1579fff7
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0005-9400000000-708e258e692a0abfbc92
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-0002-9100000000-7d75e23ae6944c1e9c6d
LC-MS/MS Spectrum - LC-ESI-QQ , negativeLC-MS/MSsplash10-001m-9000000000-fb80dcbab23323a042af
MS/MS Spectrum - , positiveLC-MS/MSsplash10-001i-1900000000-76ae33b45e4348d50b07
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a59-0900000000-888595fb43d28adcf88a
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-00p3-3900000000-0c4c20138fa1a0f921d4
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0a4i-3900000000-1080b483e877984462e0
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0600-5900000000-129e12b626cf910213f2
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-004i-9100000000-d90db3567dc1b7b3c201
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-014i-5900000000-eb892c00812eeb8022c1
1H NMR Spectrum1D NMRNot Applicable
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
[1H,1H] 2D NMR Spectrum2D NMRNot Applicable
[1H,13C] 2D NMR Spectrum2D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-145.2842277
predicted
DarkChem Lite v0.1.0
[M-H]-142.2891902
predicted
DarkChem Standard v0.1.0
[M-H]-145.5274277
predicted
DarkChem Lite v0.1.0
[M-H]-145.7220277
predicted
DarkChem Lite v0.1.0
[M-H]-134.65358
predicted
DeepCCS 1.0 (2019)
[M+H]+148.5023277
predicted
DarkChem Lite v0.1.0
[M+H]+146.9305277
predicted
DarkChem Lite v0.1.0
[M+H]+146.5963277
predicted
DarkChem Lite v0.1.0
[M+H]+146.5342277
predicted
DarkChem Lite v0.1.0
[M+H]+137.04913
predicted
DeepCCS 1.0 (2019)
[M+Na]+146.1642277
predicted
DarkChem Lite v0.1.0
[M+Na]+146.0345277
predicted
DarkChem Lite v0.1.0
[M+Na]+146.1695277
predicted
DarkChem Lite v0.1.0
[M+Na]+145.9266277
predicted
DarkChem Lite v0.1.0
[M+Na]+144.47086
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Thrombospondin receptor activity
Specific Function
Thrombin, which cleaves bonds after Arg and Lys, converts fibrinogen to fibrin and activates factors V, VII, VIII, XIII, and, in complex with thrombomodulin, protein C. Functions in blood homeostas...
Gene Name
F2
Uniprot ID
P00734
Uniprot Name
Prothrombin
Molecular Weight
70036.295 Da
References
  1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Receptor binding
Specific Function
Pro-inflammatory cytokine. Involved in the innate immune response to bacterial pathogens. The expression of MIF at sites of inflammation suggests a role as mediator in regulating the function of ma...
Gene Name
MIF
Uniprot ID
P14174
Uniprot Name
Macrophage migration inhibitory factor
Molecular Weight
12476.19 Da
References
  1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Kind
Protein
Organism
Aquifex aeolicus (strain VF5)
Pharmacological action
Unknown
General Function
Prephenate dehydrogenase activity
Specific Function
Not Available
Gene Name
tyrA
Uniprot ID
O67636
Uniprot Name
Prephenate dehydrogenase
Molecular Weight
34849.26 Da
References
  1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]

Drug created at September 15, 2010 21:25 / Updated at June 12, 2020 16:52